TY  - GEN
AU  - Huang,Yu-Chung
AU  - Liu,Chia-Jen
AU  - Liu,Chun-Yu
AU  - Pai,Jih-Tung
AU  - Hong,Ying-Chung
AU  - Teng,Hao-Wei
AU  - Hsiao,Liang-Tsai
AU  - Chao,Ta-Chung
AU  - Gau,Jyh-Pyng
AU  - Liu,Jin-Hwang
AU  - Hsu,Hui-Chi
AU  - Chiou,Tzeon-Jye
AU  - Chen,Po-Min
AU  - Yu,Yuan-Bin
AU  - Tzeng,Cheng-Hwai
TI  - Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma
SN  - 1432-0584
PY  - 2011///1027
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - China
KW  - epidemiology
KW  - Cohort Studies
KW  - Disease Susceptibility
KW  - chemically induced
KW  - Drug Monitoring
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Lung Diseases, Interstitial
KW  - complications
KW  - Lymphocyte Count
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - blood
KW  - Lymphopenia
KW  - etiology
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Rituximab
KW  - Survival Analysis
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00277-011-1268-2
ER  -